Gordon Bernard Archives
Jul. 8, 2019—A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
Feb. 13, 2019—IBM Watson Health has announced plans to make a 10-year, $50 million investment in joint research collaborations with Brigham and Women’s Hospital — the teaching hospital of Harvard Medical School — and Vanderbilt University Medical Center to advance the science of artificial intelligence (AI) and its application to major public health issues.
Dec. 6, 2018—The new Round Wing location of Vanderbilt University Medical Center’s Elliot V. Newman Clinical Research Center (CRC) opened Dec. 4 with a ribbon-cutting and reception.
Feb. 15, 2018—A clinical trial of an intervention for sepsis in patients in Zambia, led by Vanderbilt investigators, topped the list of 2017 trials featured by the website The Bottom Line.
Feb. 8, 2018—Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe.
Oct. 19, 2017—Clinical and translational research at Vanderbilt University Medical Center (VUMC) is thriving.
Jun. 8, 2017—Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH).
Sep. 29, 2016—Gordon Bernard, M.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC), will receive the American College of Critical Care Medicine’s highest honor, the Distinguished Investigator Award, during the Society of Critical Care Medicine’s (SCCM) 46th Critical Care Congress in Honolulu in January, 2017.
Jul. 5, 2016—Researchers at Vanderbilt University Medical Center and Duke Clinical Research Institute have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently.
VUMC and Celgene Corporation enter into research agreement to accelerate development of next-generation therapeutics
Apr. 4, 2016—Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.